Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study ...Middle East

SHANGHAI, July 31, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment for...

Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study )

Also on site :

• Israeli embassy worker couple shot dead outside Jewish museum in Washington DC by gunman chanting ‘Free Palestine’
• Suspect in shooting that killed 2 Israeli embassy staffers chanted ‘free, free Palestine’ after arrest: DC police chief
• Mexican cartel turf war forces evacuation of exotic animals